The Role of the Amylin Analogue Cagrilintide in Bone Metabolism | MicrobiomeTrials← Back to trialsNCT07010432
The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2025-06-12Est. Completion: 2028-05-03
Enrollment target: 144 participants Locations- Steno Diabetes Center Copenhagen, Herlev, Denmark
Other microbiome trials you might be interested in
UltrasonographyAirway ManagementIntubation, IntratrachealObesity and Overweight
Obese patients are at increased risk of difficult airway management due to anatomical changes in the anterior neck soft …
Multiple LocationsEst. completion Oct 20, 2026
Insulin ResistanceObesity
Background:
Obesity and related illnesses cause at least 2.8 million deaths each year worldwide. Few treatments exist f…
Bethesda, United StatesEst. completion Mar 1, 2030
Obesity (Disorder)
This randomized crossover clinical trial aims to evaluate the effect of a synbiotic containing Lactobacillus acidophilus…
Huixquilucan, MexicoEst. completion Feb 2, 2027